Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
The Associated Press

The Latest: Jury to resume deliberations in Hunter Biden's federal gun trial

Copyright 2024 The Associated Press. All rights reserved.

The Latest on Hunter Biden’s federal gun trial (all times local):

Jurors will resume deliberations Tuesday in the criminal case against Hunter Biden over a gun he bought in 2018 when prosecutors say he was in the throes of a crack cocaine addiction.

Jurors deliberated for less than an hour Monday afternoon before leaving the federal courthouse in Delaware. They're weighing whether President Joe Biden's son is guilty of three felonies in the case pitting him against his father’s Justice Department in the middle of the Democratic president’s reelection campaign.

Prosecutors spent last week using testimony from his ex-wife and former girlfriends, photos of him with drug paraphernalia and other tawdry evidence to make the case that he lied when he checked “no” on the form at the gun shop that asked whether he was “an unlawful user of, or addicted to” drugs.

Currently:

— Jurors will resume deliberations in the federal gun case against President Joe Biden’s son Hunter

Here's the latest:

What to know about the Hunter Biden gun trial

The trial began last week in Delaware’s federal court with prosecutors seeking to show Hunter Biden was addicted and regularly using drugs during the 11-day period when he bought and owned the gun.

Hunter Biden’s defense team sought to show he didn't consider himself an “addict” when he filled out the form and said he was trying to turn his life around at the time.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.